Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Illegal veterinary medicines a ‘significant and growing problem’
Illegal veterinary medicines comprise of counterfeit, falsified and unregistered products.
Report identifies risks to animals and humans 

Illegal veterinary medicines are costing the global animal health industry an estimated $1-2 billion per year, according to a report by the global medicines association, HealthforAnimals.

The report, Illegal Veterinary Medicines: Impacts and Effective Control, is the first ever assessment of illegal veterinary medicines. It outlines the size of the illegal veterinary medicines market and identifies some of the major risks to animals, vets, people and business.

“For the Animal Health industry as a whole, illegal veterinary medicines are a significant and growing problem,” the report notes. “The continuing rapid growth in online buying and selling of products (e-commerce) and a parallel growth in international trade especially of small packages, has created new opportunities for trade in illegal veterinary medicines.”

Illegal veterinary medicines comprise of counterfeit, falsified and unregistered products and unapproved parallel imports. They also include compounded pharmaceuticals and illegal autogenous vaccines when these products are not manufactured according to regulation.

Risks identified by the report include damage to business reputation arising from safety issues and the associated loss of confidence in authentic medicines. It also notes a risk to human safety through the consumption of food from animals treated with illegal medicines, less effective control of zoonotic infections and risks of increasing antimicrobial and antiparasitic resistance.

The report makes a number of recommendations to develop an effective strategy for the control of illegal veterinary medicines. They include communicating an effective narrative with an emphasis on safety, collaborating with enforcement agencies, and using data to show trends and case studies.

HealthforAnimals says that it may take up to seven years and appropriate resources for the recommendations to come into effect and to see the full impact on illegal veterinary medicines.

Become a member or log in to add this story to your CPD history

Greyhound Board announces change to vaccination guidance

News Story 1
 The Greyhound Board of Great Britain has published new vaccination guidance, with all greyhounds registered from 1 January, 2027 required to have the L4 leptospirosis vaccination, rather than L2.

The change comes in response to the reduced availability of the 'L2' Leptospirosis vaccine across the UK, and aims to support best biosecurity practice across the racing greyhound population.

GBGB veterinary director Simon Gower, said "While rare, Leptospirosis is a serious infectious disease that can affect both dogs and humans, so it is vital that we offer our greyhounds the broadest possible protection.  

Click here for more...
News Shorts
Free webinar explores congenital heart disease in dogs

A free webinar is to provide veterinary professionals, dog breeders and pet owners an new insights into congenital heart disease.

Chris Linney, a cardiology specialist and Veterinary Cardiovascular Society (VSC) member, will present the webinar from 7.00pm to 8.30pm on Wednesday, 12 November.

Dr Linney will explore the types, causes and clinical presentation of congenital heart conditions. This will include diagnostic approaches, treatment pathways and emerging research opportunities.

The session is the third to be organised by The Kennel Club, with the VCS, following an introductory webinar and a talk on acquired heart disease. Dr Linney's webinar consists of a one-hour presentation, followed by a 30-minute question and answer session.

Dr Linney said: "This webinar will be an opportunity to deepen understanding - not just of the diseases themselves, but of how breeders, vets and owners can work together to support affected dogs and improve outcomes for future generations."

Click here to register for the webinar.